skip to Main Content
Phone: 301-655-1084 Email: info@glycorx.com

SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes

GlycoMantra has been awarded a two-year SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted…

Read more

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH) June 03, 2020 GlycoMantra…

Read more

GlycoMantra will present at the Oncology Investor Conference.

GlycoMantra will present at the Oncology Investor Conference. GlycoMantra has been selected to pitch at the…

Read more

Glycomantra Will Present At RESI Europe

GlycoMantra has been selected to pitch in the Featured Company Pitch Session at RESI Europe meeting.

Read more
Back To Top